Search for
Menu
About
+
Overview
Impact
Partners
Team
Entrepreneurs
+
Work with Us
Industries
Internship Program
Innovation Center
Mentors
Corporates
Capital
+
Rev1 Capital
Funds
Portfolio
Resources
+
Startup Resources
Blog
Entrepreneur Toolkit
Jobs
Events
Get Started
About
+
Overview
Impact
Partners
Team
Entrepreneurs
+
Work with Us
Industries
Internship Program
Innovation Center
Mentors
Corporates
Capital
+
Rev1 Capital
Funds
Portfolio
Resources
+
Startup Resources
Blog
Entrepreneur Toolkit
Jobs
Events
Get Started
Search for
Press Tag:
Clarametyx Biosciences
Categories
Categories
Filter by Topics
Business
Capital
Getting Customers
Getting Funding
Getting Started
Inclusive Entrepreneurship
Market
Press
Product
Rev1 News
Startup Buzz
Team
The Hard Stuff
Uncategorized
VC Trends
Clarametyx Biosciences Announces FDA Grant Of Fast Track And Qualified Infectious Disease Product Designations For CMTX-101
Company News
08/04/2025
Clarametyx Biosciences Announces FDA Grant Of Fast Track And Qualified Infectious Disease Product Designations For CMTX-101
Clarametyx Biosciences Announces Positive Interim Analysis in Phase 2a Study Evaluating CMTX-101 for Infections Associated with Cystic Fibrosis
Company News
06/16/2025
Clarametyx Biosciences Announces Positive Interim Analysis in Phase 2a Study Evaluating CMTX-101 for Infections Associated with Cystic Fibrosis
CincyTech Invests in Clarametyx to Advance Breakthrough Anti-Biofilm Therapies for Chronic Respiratory Disease
Company News, Funding News
05/01/2025
CincyTech Invests in Clarametyx to Advance Breakthrough Anti-Biofilm Therapies for Chronic Respiratory Disease
Clarametyx Biosciences Awarded a Multi-Phased Agreement With CARB-X to Accelerate Anti-Biofilm Vaccine to Prevent Bacterial Infections
Company News
01/07/2025
Clarametyx Biosciences Awarded a Multi-Phased Agreement With CARB-X to Accelerate Anti-Biofilm Vaccine to Prevent Bacterial Infections
Clarametyx Bioscience Recognized as “Infectious Disease Innovation of the Year” In 2024 BioTech Breakthrough Awards
Company News
11/19/2024
Clarametyx Bioscience Recognized as “Infectious Disease Innovation of the Year” In 2024 BioTech Breakthrough Awards
Clarametyx Biosciences Initiates Phase 2a Trial for CMTX-101 in Cystic Fibrosis Patients
Company News
10/24/2024
Clarametyx Biosciences Initiates Phase 2a Trial for CMTX-101 in Cystic Fibrosis Patients
Top Tech Companies In Ohio To Watch in 2025
Company News, Rev1 News
10/14/2024
Top Tech Companies In Ohio To Watch in 2025
Nationwide Children’s infection-busting treatment gets pivotal tests
01/22/2024
Nationwide Children’s infection-busting treatment gets pivotal tests
Clarametyx Biosciences Announces $33M Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections
Funding News
01/05/2024
Clarametyx Biosciences Announces $33M Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections
Search for
All Blogs
Topics
Business
Capital
Getting Customers
Getting Funding
Getting Started
Inclusive Entrepreneurship
Market
Press
Product
Rev1 News
Startup Buzz
Team
The Hard Stuff
Uncategorized
VC Trends
1
2
Next »
